Seven Years of Active Thyroid Hormone Research in Germany: Thyroid
                    Hormone Action beyond Classical Concepts

Heike Biebermann; Klaudia Brix; Dagmar Führer

doi:10.1055/a-1163-7355

Experimental and Clinical Endocrinology & Diabetes, Table of Contents

Exp Clin Endocrinol Diabetes 2020; 128(06/07): 355-357
DOI: 10.1055/a-1163-7355

Editorial

Seven Years of Active Thyroid Hormone Research in Germany: Thyroid Hormone Action beyond Classical Concepts

Heike Biebermann‡

¹Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health; Institut für Experimentelle Pädiatrische Endokrinologie, Berlin, Germany

,

Klaudia Brix‡

²Department of Life Sciences and Chemistry, Jacobs University Bremen, Bremen, Germany

,

Dagmar Führer ‡

³Universität Duisburg-Essen, Universitätsklinikum Essen, Klinik für Endokrinologie, Diabetologie und Stoffwechsel, Zentrallabor - Bereich Forschung und Lehre, Essen, Germany

› Author Affiliations

Abstract

Key words

thyoid hormone - transporter - receptor

Full Text

References

References
1 Friesema EC, Ganguly S, Abdalla A. et al. Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem 2003; 278: 40128-40135.
2 Scanlan TS, Suchland KL, Hart ME. et al. 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nat Med 2004; 10: 638-642.
3 Kerp H, Gassen J, Fuhrer D. Age and sex influence thyroid hormone effects in target tissues with organ-specific responses. Exp Clin Endocrinol Diabetes. 2020 DOI: 10.1055/a-1083-6272
4 Friedrich N, Pietzner M, Engelmann B. et al. Screening for new markers to assess thyroid hormone action by OMICs analysis of human sample. Experimental and Clinical Endocrinology and Diabetes 2020; 128: 479-487
5 Homut GL, Schanze J, Golchert N. et al. Endocrine, metabolic and pharmacological effects of thyronamines (TAM), thyroacetic acids (TA) and thyroid hormone metabolites (THM) – Evidence from in vitro, cellular, experimental animal and human studies. Experimental and Clinical Endocrinology and Diabetes 2020; 128: 401-413
6 Köhrle JR. K. Mass spectrometry-based determination of thyroid hormones and their metabolites in endocrine diagnostics and biomedical research – implications for human serum diagnostics. Experimental and Clinical Endocrinology and Diabetes 2020; 128: 358-374
7 Muller-Fielitz H, Schwaninger M. The role of tanycytes in the hypothalamus-pituitary-thyroid axis and the possibilities for their genetic manipulation. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1065-1855
8 Braun D, Schweizer U. Thyroid hormone transport and transporters. Vitam Horm 2018; 106: 19-44. DOI: 10.1016/bs.vh.2017.04.005
9 Krause G, Hinz KM. Molecular mechanisms of thyroid hormone transport by l-type amino acid transporter. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1032-8369
10 Salveridou E, Mayerl S, Sundaram SM. et al. Tissue-specific function of thyroid hormone transporters: New insights from mouse models. Exp Clin Endocrinol Diabetes. 2019
11 Steegborn C, Schweizer U. Structure and Mechanism of iodothyronine deiodinases – what we know, what we don't know, and what would be nice to know. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1022-9916
12 Hönes S, Geist D, Moeller LC. Noncanonical action of thyroid hormone receptors α and β. Experimental and Clinical Endocrinology and Diabetes 2020; 128: 383-387
13 Mittag J. More Than Fever – Novel concepts in the regulation of body temperature by thyroid hormones. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1014-2510
14 Gobel A, Gottlich M, Reinwald J. et al. The influence of thyroid hormones on brain structure and function in humans. Exp Clin Endocrinol Diabetes. 2020
15 Krause K.. Novel aspects of white adipose tissue browning by thyroid hormones. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1020-5354
16 Brix K, Szumska J, Weber J. et al. Auto-regulation of the thyroid gland beyond classical pathways. Exp Clin Endocrinol Diabetes. 2020
17 Lademann F, Tsourdi E, Hofbauer LC. et al. Thyroid hormone actions and bone remodeling – the role of the wnt signaling pathway. Exp Clin Endocrinol Diabetes. 2020
18 Schmohl KA, Muller AM, Nelson PJ. et al. Thyroid hormone effects on mesenchymal stem cell biology in the tumour microenvironment. Exp Clin Endocrinol Diabetes. 2019
19 Kube I, Zwanziger D.. Thyroid dysfunction and cholesterol gallstone disease. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1033-7273
20 Hoefig CS, Zucchi R, Kohrle J.. Thyronamines and derivatives: physiological relevance, pharmacological actions, and future research directions. Thyroid 2016; 26: 1656-1673. DOI: 10.1089/thy.2016.0178
21 Kohrle J, Biebermann H.. 3-Iodothyronamine-A Thyroid Hormone Metabolite With Distinct Target Profiles and Mode of Action. Endocr Rev 2019; 40: 602-630 DOI: 10.1210/er.2018-00182
22 Biebermann H, Kleinau G.. 3-Iodothyronamine Induces Diverse Signaling Effects at Different Aminergic and Non-Aminergic G-Protein Coupled Receptors. Exp Clin Endocrinol Diabetes. 2019 DOI: 10.1055/a-1022-1554
23 Coster M, Biebermann H, Schoneberg T. et al. Evolutionary Conservation of 3-Iodothyronamine as an Agonist at the Trace Amine-Associated Receptor 1. Eur Thyroid J 2015; 4: 9-20.
24 Walcher L, Budde C, Bohm A. et al. TRPM8 Activation via 3-Iodothyronamine Blunts VEGF-Induced Transactivation of TRPV1 in Human Uveal Melanoma Cells. Front Pharmacol 2018; 9: 1234.
25 Wirth EK, Meyer F.. Neuronal effects of thyroid hormone metabolites. Mol Cell Endocrinol 2017; 458: 136-142 DOI: 10.1016/j.mce.2017.01.007
26 Nock S, Hofig C, Harder L. et al. Unraveling the molecular basis for successful thyroid hormone replacement therapy: The need for new thyroid tissue- and pathway-specific biomarkers. Exp Clin Endocrinol Diabetes. 2019